Toshihiro Misumi

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer

Daisuke Kotani, Eiji Oki, Yoshiaki Nakamura et al. · Nature Medicine · 2023 · 468 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer

Jun Watanabe, Kei Muro, Kohei Shitara et al. · JAMA · 2023 · 258 citations · Full text

Medicine, Oncology, Pharmacology +17

ctDNA-based molecular residual disease and survival in resectable colorectal cancer

Yoshiaki Nakamura, Jun Watanabe, Naoya Akazawa et al. · Nature Medicine · 2024 · 190 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction

Masaaki Konishi, Nobuyuki Kagiyama, Kentaro Kamiya et al. · European Journal of Preventive Cardiology · 2020 · 182 citations

Medicine, Cardiology, Geriatric Medicine +17

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer

Kohei Shitara, Kei Muro, Jun Watanabe et al. · Nature Medicine · 2024 · 110 citations · Full text

Medicine, Oncology, Pharmacology +17